Gilead’s Quad pill likely to gain FDA nod given its inclusion in latest HIV therapy guidelines
...The inclusion of Quad in the guidelines shows IAS-USA is being proactive, as it is “hard not to see” the Quad as a treatment option soon, said Dr David Margolis, professor of Medicine, Microbiology and Immunology, and Epidemiology at the University of North Carolina.
CDC moves to keep new resistant gonorrhea at bay
Federal health officials took steps Thursday to head off the emergence of a new gonorrhea "superbug" that's resistant to standard antibiotics. ...Now, "we're at the end of the line on standard therapies," says P. Frederick Sparling, a professor of medicine at the University of North Carolina-Chapel Hill.
State and local coverage
Study finds help with chronic venous leg ulcers
The Herald-Sun (Durham)
Treating chronic venous leg ulcers with a topical spray containing a unique living human cell formula provides a 52 percent greater likelihood of wound closure than treatment with compression bandages only. That's the conclusion of a new study conducted in part at the University of North Carolina School of Medicine and published online by The Lancet last week.
Dozens to get drugs for HIV
The Winston-Salem Journal
...A 2011 study at UNC Chapel Hill found that treating HIV-infected individuals with antiretroviral therapy when their immune systems are relatively healthy leads to a 96 percent reduction in HIV transmission to their partners. This finding suggests that early treatment of infected individuals can have a major impact on the spread of HIV disease.
Dads can affect child's health at birth, study finds
The News & Observer (Raleigh)
It’s long been known that the behavior and environment of the mother during pregnancy can affect a newborn’s health. But new research suggests that a father’s behavior is important, too. Scientists at UNC-Chapel Hill have found that different parental occupations may bring increased risk of birth defects.
Institute opens DNA bank to outside researchers
The Herald-Sun (Durham)
Initially, the University of North Carolina at Chapel Hill was a partner in the project, he said, and subjects were recruited at one time through UNC clinics. Later recruitment has been done through the institute alone, he said, but the institute is still pursuing followup studies in collaboration with the university.